PubMed

Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina.

Podlekareva DN, Mocroft A, Post FA, Riekstina V, Miro JM, Furrer H, Bruyand M, Panteleev AM, Rakhmanova AG, Girardi E, Losso MH, Toibaro JJ, Caylá J, Miller RF, Obel N, Skrahina A, Chentsova N, Lundgren JD, Kirk O; HIV/TB Study Writing Group.

AIDS. 2009 Nov 27;23(18):2485-95.PMID: 19898216 [PubMed - in process]Related articles

Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements.

antiretroviral therapy cohort collaboration (ART-CC), Lanoy E, May M, Mocroft A, Phillip A, Justice A, Chêne G, Furrer H, Sterling T, Monforte AD, Force L, Gill J, Harris R, Hogg RS, Rockstroh J, Saag M, Khaykin P, de Wolf F, Sterne JA, Costagliola D.

AIDS. 2009 Oct 23;23(16):2199-208.PMID: 19779320 [PubMed - in process]Related articles

Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression.

Moore DM, Harris R, Lima V, Hogg B, May M, Yip B, Justice A, Mocroft A, Reiss P, Lampe F, Chêne G, Costagliola D, Elzi L, Mugavero MJ, Monforte AD, Sabin C, Podzamczer D, Fätkenheuer G, Staszewski S, Gill J, Sterne JA; Antiretroviral Therapy Cohort Collaboration.

J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):357-63.PMID: 19668084 [PubMed - indexed for MEDLINE]Related articles

Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy.

Kesselring AM, Wit FW, Sabin CA, Lundgren JD, Gill MJ, Gatell JM, Rauch A, Montaner JS, de Wolf F, Reiss P, Mocroft A; Nevirapine Toxicity Multicohort Collaboration.

AIDS. 2009 Aug 24;23(13):1689-99.PMID: 19487907 [PubMed - in process]Related articles

Hepatitis C virus coinfection does not influence the CD4 cell recovery in HIV-1-infected patients with maximum virologic suppression.

Peters L, Mocroft A, Soriano V, Rockstroh JK, Losso M, Valerio L, Aldins P, Reiss P, Ledergerber B, Lundgren JD; EuroSIDA Study Group.

J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):457-63.PMID: 19360931 [PubMed - indexed for MEDLINE]Related articles

Absence of a relation between efavirenz plasma concentrations and toxicity-driven efavirenz discontinuations in the EuroSIDA study.

van Luin M, Bannister WP, Mocroft A, Reiss P, Di Perri G, Peytavin G, Molto J, Karlson A, Castagna A, Beniowski M, Lundgren JD, Burger DM; EuroSIDA Study Group.

Antivir Ther. 2009;14(1):75-83.PMID: 19320239 [PubMed - indexed for MEDLINE]Related articles

Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal.

Antiretroviral Therapy Cohort Collaboration (ART-CC), Mocroft A, Sterne JA, Egger M, May M, Grabar S, Furrer H, Sabin C, Fatkenheuer G, Justice A, Reiss P, d'Arminio Monforte A, Gill J, Hogg R, Bonnet F, Kitahata M, Staszewski S, Casabona J, Harris R, Saag M.

Clin Infect Dis. 2009 Apr 15;48(8):1138-51.PMID: 19275498 [PubMed - indexed for MEDLINE]Related articles

Use of risk equations for predicting disease progression in HIV infection.

Mocroft A, Lundgren JD.

Clin Infect Dis. 2009 Apr 1;48(7):951-3. No abstract available. PMID: 19226232 [PubMed - indexed for MEDLINE]Related articles

Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies.

Harris RJ, Sterne JA, Abgrall S, Dabis F, Reiss P, Saag M, Phillips AN, Chêne G, Gill JM, Justice AC, Rockstroh J, Sabin CA, Mocroft A, Bucher HC, Hogg RS, Monforte AD, May M, Egger M; Antiretroviral Therapy Cohort Collaboration.

Antivir Ther. 2008;13(8):959-67.PMID: 19195321 [PubMed - indexed for MEDLINE]Related articles

Interruption of antiretroviral therapy is associated with increased plasma cystatin C.

Mocroft A, Wyatt C, Szczech L, Neuhaus J, El-Sadr W, Tracy R, Kuller L, Shlipak M, Angus B, Klinker H, Ross M; INSIGHT SMART Study Group.

AIDS. 2009 Jan 2;23(1):71-82.PMID: 19050388 [PubMed - indexed for MEDLINE]Related articles

Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?

Reekie J, Mocroft A, Sambatakou H, Machala L, Chiesi A, van Lunzen J, Clumeck N, Kirk O, Gazzard B, Lundgren JD; EuroSIDA Study Group.

AIDS. 2008 Nov 12;22(17):2381-90.PMID: 18981778 [PubMed - indexed for MEDLINE]Related articles

Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study.

Tedaldi E, Peters L, Neuhaus J, Puoti M, Rockstroh J, Klein MB, Dore GJ, Mocroft A, Soriano V, Clotet B, Lundgren JD; SMART Study Group and International Network for Strategic Initiatives in Global HIV Trials (INSIGHT).

Clin Infect Dis. 2008 Dec 1;47(11):1468-75.PMID: 18959492 [PubMed - indexed for MEDLINE]Related articles

The EuroSIDA study: Regional differences in the HIV-1 epidemic and treatment response to antiretroviral therapy among HIV-infected patients across Europe--a review of published results.

Podlekareva D, Bannister W, Mocroft A, Abrosimova L, Karpov I, Lundgren JD, Kirk O; EuroSIDA Study Group.

Cent Eur J Public Health. 2008 Sep;16(3):99-105. Review.PMID: 18935770 [PubMed - indexed for MEDLINE]Related articles

Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study.

Cozzi-Lepri A, Phillips AN, Clotet B, Mocroft A, Ruiz L, Kirk O, Lazzarin A, Wiercinska-Drapalo A, Karlsson A, Lundgren JD; EuroSIDA Study Group.

AIDS. 2008 Oct 18;22(16):2187-98.PMID: 18832882 [PubMed - indexed for MEDLINE]Related articles

Incidence of abacavir hypersensitivity reactions in euroSIDA.

Bannister WP, Friis-Møller N, Mocroft A, Viard JP, van Lunzen J, Kirk O, Gargalianos P, Bánhegyi D, Chiesi A, Lundgren JD; EuroSIDA Study Group.

Antivir Ther. 2008;13(5):687-96.PMID: 18771052 [PubMed - indexed for MEDLINE]Related articles

Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe.

Soriano V, Mocroft A, Rockstroh J, Ledergerber B, Knysz B, Chaplinskas S, Peters L, Karlsson A, Katlama C, Toro C, Kupfer B, Vogel M, Lundgren J; EuroSIDA Study Group.

J Infect Dis. 2008 Nov 1;198(9):1337-44.PMID: 18767985 [PubMed - indexed for MEDLINE]Related articles

Fungal infection as a risk factor for HIV disease progression among patients with a CD4 count above 200/microl in the era of cART.

Podlekareva D, Mocroft A, Kirk O, Reiss P, Aldins P, Katlama C, Kovari H, Stellbrink HJ, D'Arminio Monforte A, Lundgren JD; Eurosida Study Group.

Scand J Infect Dis. 2008;40(11-12):908-13.PMID: 18609197 [PubMed - indexed for MEDLINE]Related articles

Transmitted drug resistant HIV-1 and association with virologic and CD4 cell count response to combination antiretroviral therapy in the EuroSIDA Study.

Bannister WP, Cozzi-Lepri A, Clotet B, Mocroft A, Kjaer J, Reiss P, von Wyl V, Lazzarin A, Katlama C, Phillips AN, Ruiz L, Lundgren JD; EuroSIDA study group.

J Acquir Immune Defic Syndr. 2008 Jul 1;48(3):324-33.PMID: 18545152 [PubMed - indexed for MEDLINE]Related articles

Analysis of the incidence and mortality of vulval cancer in women in South East England 1960-1999.

Somoye GO, Mocroft A, Olaitan A.

Arch Gynecol Obstet. 2009 Feb;279(2):113-7. Epub 2008 May 17.PMID: 18488239 [PubMed - indexed for MEDLINE]Related articles

Incidence of pancreatitis in HIV-infected patients, and the association with antiretroviral therapy.

Smith CJ, Mocroft A, Lundgren JD; EuroSIDA Study Group.

AIDS. 2008 May 11;22(8):997-8. No abstract available. PMID: 18453864 [PubMed - indexed for MEDLINE]Related articles